Trial Information
Inclusion Criteria:
- Glioblastoma and anaplastic astrocytoma, supratentorial, histologically confirmed
- Brain CT scan or MRI within 28 days before surgery
- Age: 70 years or older
- Karnofsky performance status, 70 or more.
- Life expectancy over 12 weeks
- Informed consent
Exclusion Criteria:
- Brain radiotherapy
- Chemotherapy
- Severe systemic disease
Type of Study:
Interventional
Study Design:
Allocation: Randomized, Endpoint Classification: Pharmacokinetics/Dynamics Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Outcome Measure:
Survival
Principal Investigator
jean-yves Delattre, MD
Investigator Role:
Principal Investigator
Investigator Affiliation:
Assistance Publique - Hôpitaux de Paris
Authority:
France: Ministry of Health
Study ID:
PHRC, P000502 AOM 98071
NCT ID:
NCT00430911
Start Date:
February 2001
Completion Date:
Related Keywords:
- Primary Brain Tumor
- Anaplastic Astrocytoma
- Glioblastoma Multiforme
- malignant gliomas
- Astrocytoma
- Brain Neoplasms
- Glioblastoma